Valens Excited for Second Wave of Cannabis Legalization

Cannabis Investing News
CSE:VGW

Valens GroWorks (CSE:VGW) (OTC:VGWCF) CEO Tyler Robson joined Capital Ideas Radio recently to speak with host Mark Bunting regarding the company’s progress in the cannabis derivatives space.

Valens GroWorks (CSE:VGW) (OTC:VGWCF) CEO Tyler Robson joined Capital Ideas Radio recently to speak with host Mark Bunting regarding the company’s progress in the cannabis derivatives space. The company has been working to perfect its extraction methods in anticipation of the second wave of legalization, which will see the Canadian government create a regulatory framework for the production, distribution and sale of cannabis derivatives like edibles, tinctures and other goods. The company has positioned itself as a leader in the Canadian cannabis extraction business, which it hopes to offer as a white label service to other cannabis companies looking to manufacture cannabis derivatives.

“If you look at October, that’s when Health Canada is launching beverages, edibles, concentrates, and basically any type of derivative. If you look at the way Valens is positioned, any ancillary product has to get extracted first. So we’re uniquely positioned to tap into that market and be an effective and dominant player when legalization 2.0 comes.”

According to Robson, there are a number of consumer packaged goods companies eager to enter the cannabis space, however many can afford to be patient as the legalization of cannabis rolls out. As a leader in Canadian cannabis extraction, Valens has positioned itself to offer white label services to these companies that wish to join the cannabis industry but do not otherwise have the ability to manufacture cannabis derivatives. Robson believes that the cannabis industry will shift away from flower, creating a unique opportunity for Valens as it positions itself as Canadian extraction leaders.

To listen to the full interview, click here.

Click here to connect with Valens GroWorks (CSE:VGW) for an Investor Presentation.

The Conversation (0)
×